Clinical Feed

Comment on Revised ISHAM-ABPA Guidelines for Diagnosing and Treating ABPA/Mycoses

Comment on diagnostic criteria for ABPA/Mycoses proposed by ISHAM, with context on Aspergillus fumigatus sensitisation and ABPA progression in adult asthma patients.

GIST

Extract We read with great interest the diagnostic criteria for allergic bronchopulmonary aspergillosis/mycoses (ABPA/M) proposed by the International Society for Human and Animal Mycology (ISHAM) working group [1], that was recently published in the European Respiratory Journal . A garwal et al . [2] reported that Aspergillus fumigatus sensitisation affects up to 25% of adult asthmatic patients presenting to tertiary care centres, with nearly 37% of sensitised individuals progressing to ABPA.

Clinical Editorial

European Respiratory Journal published a clinical update in Critical Care on 02 Apr 2026. The item focuses on Comment on: Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses. Review the original article for the full source wording and details.

Original source: http://erj.ersjournals.com/cgi/content/short/67/4/2501724?rss=1